Sinsimer Daniel, Huet Gaelle, Manca Claudia, Tsenova Liana, Koo Mi-Sun, Kurepina Natalia, Kana Bavesh, Mathema Barun, Marras Salvatore A E, Kreiswirth Barry N, Guilhot Christophe, Kaplan Gilla
Laboratory of Mycobacterial Immunity and Pathogenesis, Public Health Research Institute Center, University of Medicine and Dentistry of New Jersey, 225 Warren St., Newark, NJ 07103, USA.
Infect Immun. 2008 Jul;76(7):3027-36. doi: 10.1128/IAI.01663-07. Epub 2008 Apr 28.
Mycobacterium tuberculosis possesses a diversity of potential virulence factors including complex branched lipids such as the phenolic glycolipid PGL-tb. PGL-tb expression by the clinical M. tuberculosis isolate HN878 has been associated with a less efficient Th1 response and increased virulence in mice and rabbits. It has been suggested that the W-Beijing family is the only group of M. tuberculosis strains with an intact pks1-15 gene, required for the synthesis of PGL-tb and capable of producing PGL-tb. We have found that some strains with an intact pks1-15 do not produce PGL-tb while others may produce a variant of PGL-tb. We examined the early host cytokine response to infection with these strains in vitro to better understand the effect of PGL-tb synthesis on immune responses. In addition, we generated a PGL-tb-producing H37Rv in order to determine the effect of PGL-tb production on the host immune response during infection by a strain normally devoid of PGL-tb synthesis. We observed that PGL-tb production by clinical M. tuberculosis isolates affected cytokine production differently depending on the background of the strain. Importantly, while ectopic PGL-tb production by H37Rv suppressed the induction of several pro- and anti-inflammatory cytokines in vitro in human monocytes, it did not lead to increased virulence in infected mice and rabbits. Collectively, our data indicate that, while PGL-tb may play a role in the immunogenicity and/or virulence of M. tuberculosis, it probably acts in concert with other bacterial factors which seem to be dependent on the background of the strain.
结核分枝杆菌拥有多种潜在的毒力因子,包括复杂的分支脂质,如酚糖脂PGL-tb。临床结核分枝杆菌分离株HN878表达PGL-tb与小鼠和兔子体内Th1反应效率降低及毒力增加有关。有人提出,W-北京家族是结核分枝杆菌菌株中唯一具有完整pks1-15基因的群体,该基因是合成PGL-tb所必需的,并且能够产生PGL-tb。我们发现,一些具有完整pks1-15的菌株不产生PGL-tb,而其他菌株可能产生PGL-tb的变体。我们在体外检测了宿主对这些菌株感染的早期细胞因子反应,以更好地了解PGL-tb合成对免疫反应的影响。此外,我们构建了一株能产生PGL-tb的H37Rv,以确定PGL-tb产生对通常不合成PGL-tb的菌株感染期间宿主免疫反应的影响。我们观察到,临床结核分枝杆菌分离株产生PGL-tb对细胞因子产生的影响因菌株背景而异。重要的是,虽然H37Rv异位产生PGL-tb在体外抑制了人单核细胞中几种促炎和抗炎细胞因子的诱导,但在感染的小鼠和兔子中并未导致毒力增加。总体而言,我们的数据表明,虽然PGL-tb可能在结核分枝杆菌的免疫原性和/或毒力中发挥作用,但它可能与其他细菌因子协同作用,而这些细菌因子似乎取决于菌株背景。